These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35305894)

  • 21. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
    Mengel R; Soffner M; Flores-de-Jacoby L
    J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of timing of orthodontic therapy on the outcomes of regenerative periodontal surgery in patients with stage IV periodontitis: A multicenter randomized trial.
    Jepsen K; Tietmann C; Kutschera E; Wüllenweber P; Jäger A; Cardaropoli D; Gaveglio L; Sanz Sanchez I; Martin C; Fimmers R; Jepsen S
    J Clin Periodontol; 2021 Oct; 48(10):1282-1292. PubMed ID: 34312872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. IV. A case series of infrabony defects after 10 years.
    Pretzl B; Kim TS; Holle R; Eickholz P
    J Periodontol; 2008 Aug; 79(8):1491-9. PubMed ID: 18673000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 gene polymorphisms and long-term stability following guided tissue regeneration therapy.
    De Sanctis M; Zucchelli G
    J Periodontol; 2000 Apr; 71(4):606-13. PubMed ID: 10807125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of intraosseous defects with bioabsorbable barriers alone or in combination with decalcified freeze-dried bone allograft: a randomized clinical trial.
    Trejo PM; Weltman R; Caffesse R
    J Periodontol; 2000 Dec; 71(12):1852-61. PubMed ID: 11156042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study.
    Artzi Z; Tal H; Platner O; Wasersprung N; Weinberg E; Slutzkey S; Gozali N; Carmeli G; Herzberg R; Kozlovsky A
    J Clin Periodontol; 2015 Jun; 42(6):547-56. PubMed ID: 25950086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guided tissue regeneration for periodontal infra-bony defects.
    Needleman IG; Worthington HV; Giedrys-Leeper E; Tucker RJ
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001724. PubMed ID: 16625546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guided tissue regeneration combined with bone allograft in infrabony defects: Clinical outcomes and assessment of prognostic factors.
    Majzoub J; Barootchi S; Tavelli L; Wang CW; Chan HL; Wang HL
    J Periodontol; 2020 Jun; 91(6):746-755. PubMed ID: 31680235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Adjunctive Use of Low-Level Diode Laser Biostimulation with Combined Orthodontic Regenerative Therapy.
    Attia MS; Hazzaa HH; Al-Aziz FA; Elewa GM
    J Int Acad Periodontol; 2019 Apr; 21(2):63-73. PubMed ID: 31522153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
    Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
    Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
    Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
    J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 120 infrabony defects treated with regenerative therapy: long-term results.
    Silvestri M; Rasperini G; Milani S
    J Periodontol; 2011 May; 82(5):668-75. PubMed ID: 21080788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guided tissue regeneration therapy of 203 consecutively treated intrabony defects using a bioabsorbable matrix barrier. Clinical and radiographic findings.
    Falk H; Laurell L; Ravald N; Teiwik A; Persson R
    J Periodontol; 1997 Jun; 68(6):571-81. PubMed ID: 9203101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of orthodontic intrusive movement to reduce infrabony pockets in adult periodontal patients: a case report.
    Re S; Corrente G; Abundo R; Cardaropoli D
    Int J Periodontics Restorative Dent; 2002 Aug; 22(4):365-71. PubMed ID: 12212683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of intrabony periodontal defects with enamel matrix derivative in private practice: a long-term retrospective study.
    Saito A; Nanbu Y; Nagahata T; Yamada S
    Bull Tokyo Dent Coll; 2008 May; 49(2):89-96. PubMed ID: 18776720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of a resorbable bone substitute with a resorbable membrane in the treatment of periodontal infrabony defect - A multicenter randomised controlled trial.
    Esposito M; Grusovin MG; Lambert F; Matos S; Pietruska M; Rossi R; Salhi L; Buti J
    Eur J Oral Implantol; 2015; 8(3):233-44. PubMed ID: 26355168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.